Park of the future

3 ways the Memorial Park Conservancy renovations are innovative

Memorial Park Conservancy's renovations include some projects that are rare or never been done before. Photo courtesy of MPC

Memorial Park is undergoing a huge transformation that is mixing a little bit of old with the new.

The Memorial Park Master Plan includes adding breathtaking new projects — like water features, a new athletic complex, and more — as well as conservation efforts that restore parts of the land that were native coastal prairie. The project is a collaborative effort between Memorial Park Conservancy, Uptown Houston TIRZ, and Houston Parks and Recreation Department to redevelop the 1,500-acre park.

The Master Plan is set to deliver a series of projects ahead of 2028, and there are a few initiatives that are innovative and different from other urban parks' transformations, notes MPC's president and CEO Shellye Arnold.

The Land Bridge

Photo courtesy of MPC

A big part of Memorial Park's transformation is restoring the park to native species and ecosystems.

"We're taking ball fields, parking lots, and roads and converting them back to what was here — native wetland coastal prairie," Arnold says. "This serves important stormwater purposes."

In order to connect two native coastal prairie lands on either side of Memorial Drive, MPC is building a unique 30-foot-high land bridge the size of three-and-a-half football fields. The space will be large enough that you don't even realize you're standing over a busy street, Arnold says.

The prairies will serve an important purpose for rainwater collection — a growing need within the city of Houston.

"We're channeling [rainwater] into this prairie where some of it can be absorbed, cleansed, slowed down," says Arnold. "And then what doesn't get slowed down and absorbed can flow through the prairie [on the other side], which is even bigger."

The Land Bridge also serves another purpose that park goers have wanted, Arnold says: Connectivity.

"[They] want access across the Memorial Drive — [they] want to safe access, and so this is the response. It's a pretty bold and visionary response," Arnold says.

BioCycling

Photo courtesy of MPC

In 2011, a major drought decimated the park and areas saw losses of 50 to even 90 percent of the canopy of trees. MPC and its team saved what could be saved, and the rest is serving a new purpose to the park.

"We took the trees that we lost on the drought that people felt such a tremendous loss for and ground them all up, and they are in a biocycle in a two-acre area in the back of the park," Arnold says.

The soil created — some of which includes manure from the animals at the Houston Zoo — has already been used on some plants in the park, and Arnold says those plants are thriving.

"It's cool that those those trees are giving life to the park," Arnold says.

Invasive species of trees that are plucked from out of the park are also being ground up and used in the same way.

"There isn't anything this big like this in an urban park setting like this kind of recycling effort," she says.

The biocycling process is scalable too.

"We could open this up to other organizations," Arnold says. "It's so much better ecologically to take trees and grind them up and use it inside the space rather than haul them out to landfill way outside of town and dump them."

The benefit to the program is that MPC can retain some of the soil it produces for these other organizations and use it on site.

Biodiversity initiatives and research

Photo courtesy of MPC

When putting the plans in place, MPC and its partners called on 25 of the best ecologists, as well as 50 more park and other types of consultants specializing in everything from insects and wildlife to prairies and trees.

Just as the Land Bridge is creating new prairie space, other initiatives throughout the park will be focused on eliminating invasive species and bringing back the natural ecosystem of the park.

The Easter Glades project, which is set to deliver next year, will have a habitat for fish, and will not allow any fishing or boating. Carolyn White, conservation director at MPC, is working with the Texas Wildlife Association to bring in the right species of fish.

Arnold says that MPC works with other organizations in an innovative way to bring native plants into MPC, since the park has the space for these organizations to use to cultivate and propagate plants.

"They bring their native plants and they grow them with their volunteers, and they leave us a little bit here," Arnold says. "We could never buy enough native plants to go inside this park."

Trending News

Building Houston

 
 

The Texas Medical Center Innovation Factory has named the 16 companies making up the inaugural cohort in the Innovate UK Global Incubator Programme. Photo via tmc.edu

Sixteen digital health and medical device startups founded in the United Kingdom have been selected for a customized accelerator at the Texas Medical Center's Innovation Factory.

In partnership with Innovate UK, TMCi created the Innovate UK Global Incubator Programme, a new accelerator that supports UK businesses as they build their United States go-to-market plan. The program builds the BioBridge relationship between TMC and the UK that was originally established five years ago.

“The TMC UK BioBridge program was launched with the UK Department for Business and Trade in 2018 to serve as a gateway for advancing life sciences and foster innovation and research between our two countries," says Ashley McPhail, chief external affairs and administration officer for TMC, in a news release. "We saw an opportunity to work with Innovate UK to develop a larger program with the UK after the success of the 11 companies that previously participated in our health tech accelerator."

The 16 companies will participate in the program from June to November. The cohort is expected to arrive in Houston on June 5 and have access to TMCi's facilities, network of mentors and potential clients, funding, potential customers, and curated programing — all while being a unique entry point into the US. The new offering joins three other globally recognized curriculums: Biodesign, Accelerator for Cancer Therapeutics, and Health Tech.

“TMCi nurtures long-term growth, development, and competitiveness to increase startups chances of success and global expansion," says Emily Reiser, associate director of TMC Innovation. "By bringing their novel technologies and exposing them to a curated selection of TMC’s expert network, startups receive support and evaluation to build, scale, and expand in the US market."

Two of the cohort's specialties include cardiovascular and oncology — two of TMC's strongest areas of expertise — with solutions ranging from surgical devices to AI-enabled risk stratification and hospital efficiency.

Innovate UK is the country's national innovation agency dedicated to supporting business-led innovation in all sectors.

“The United Kingdom is fully committed to improving global healthcare through scientific collaboration," says His Majesty’s Consul General in Texas Richard Hyde in the release. "Through the expansion of the TMC UK BioBridge and in partnership with Innovate UK, this programme will help to expose the brightest and best British companies to the world’s largest medical city. Our companies will collaborate and grow as they work to develop cutting edge technology. The partnership between the UK Government and TMC demonstrates that international collaboration can drive both economic growth and improvement to quality of life.”

The 16 companies making up the inaugural cohort are as follows, according to TMC.

  • AINOSTICS aims to revolutionize the treatment and prevention of neurological conditions, such as dementia, by developing innovative AI-enabled solutions that draw novel insights from routinely acquired non-invasive medical scans to deliver accurate diagnosis and outcome prediction, and in turn facilitate personalized care and timely access to disease-modifying treatments for patients.
  • Alvie is a blended human plus AI-enabled digital solution providing personalised pre and rehabilitation coaching and supportive care for cancer and surgery. Alvie's technology combines data profiling, risk-stratification and tailored prescriptions of health and well-being with curated educational content, targeted behaviour change coaching and expert support through chat messaging and virtual consultations.
  • C the Signs™ is a validated AI cancer prediction platform, which can identify patients at risk of cancer at the earliest and most curable stage of the disease. Used by healthcare professionals, C the Signs can identify which tumor type a patient is at risk of and recommend the most appropriate next step in less than 30 seconds. The platform has detected over 10,000 patients with cancer, with over 50 different types of cancer diagnosed, and with a sensitivity of >98% for cancer.
  • At PEP Health, We believe all patients deserve the best care possible. Our cutting-edge machine-learning technology enables healthcare organisations, regulators, and insurers the real-time, actionable insights they need to have a direct and dramatic impact on patient experiences.
  • PreciousMD improves the lives of lung-cancer and other lung-related illnesses patients worldwide by enabling imaging-based diagnostics needed for personalized treatment pathways.
  • Ufonia is an autonomous telemedicine company, we use large language models and voice AI to increase the capacity of clinical professionals.
  • My mhealth offers digital therapeutics for a range of long-term conditions- COPD, Asthma, Diabetes and Heart Disease. Our product has been successfully deployed in the UK and India, with >100,000 users registered to date. Our solutions empower patients to self-manage their conditions, resulting in dramatic improvements in outcomes, as evidenced through multiple clinical trials and real-world evaluations.
  • At Surgery Hero, we offer a clinically backed solution that ensures whole-human support before and after surgery. We help health systems, employers and health plans cut costs without sacrificing quality of care.
  • Panakeia's software platform enables extremely rapid multi-omics profiling in minutes directly from routinely used tissue images without needing wet lab assays.
  • QV Bioelectronics are striving to deliver longer, better quality lives for brain tumour patients. Using their first-of-its-kind implantable electric field therapy device, GRACE, QV will provide effective, focal & continuous treatment without impacting patient quality of life.
  • 52 North is a med-tech company focused on improving health outcomes and health equity by reinventing care pathways. The NeutroCheck® solution is a finger-prick blood test and digital platform built to significantly improve safety and quality of life for cancer patients, by helping to identify at-home those patients who are at risk of the most fatal side-effect of chemotherapy: neutropenic sepsis.
  • Somnus is fulfilling an unmet need in global healthcare by developing real-time, point of care blood propofol monitoring. Its products will improve the care of sedated and anaesthetised patients, save money for hospitals, and facilitate a major reduction in greenhouse gas emissions.
  • ScubaTx is a breakthrough organ transplant preservation company established to solve the global unmet need for cost-efficient and longer-duration organ preservation technology. ScubaTx has developed a simple, small and affordable device which uses Persufflation to extend the preservation of organs.
  • IBEX is on a mission to help people live active, healthy and productive lives by increasing their access to early diagnosis of osteoporosis. The IBEX BH software as medical device delvers routine, automated assessment of fracture risk from routine radiology for earlier detection and more equitable treatment of osteoporosis.
  • NuVision produces products derived from donated human amniotic membrane that are used in ophthalmology to help patients with chronic, traumatic and post-surgical wounds of the eye to be treated earlier and recover more fully and more quickly. The company’s products are also used in the management of dry eye disease, a debilitating conditions that affects around 17m people in the USA.
  • Calon Cardio-Technology is on a mission to improve quality of life for patients with Left Ventricular Assist devices (LVAD) and reduce the common post operative complications associated with these implantable heart pumps. We plan to do this by introducing a completely wireless heart pump system and augment patient follow-up with built-in remote monitoring capabilities.

Trending News